Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
about
The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature.Biology and management of relapsed acute myeloid leukaemia.Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.4-aminopyridine induces apoptosis of human acute myeloid leukemia cells via increasing [Ca2+]i through P2X7 receptor pathway.
P2860
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of patients with rec ...... armacologically based regimen.
@ast
Treatment of patients with rec ...... armacologically based regimen.
@en
Treatment of patients with rec ...... armacologically based regimen.
@nl
type
label
Treatment of patients with rec ...... armacologically based regimen.
@ast
Treatment of patients with rec ...... armacologically based regimen.
@en
Treatment of patients with rec ...... armacologically based regimen.
@nl
prefLabel
Treatment of patients with rec ...... armacologically based regimen.
@ast
Treatment of patients with rec ...... armacologically based regimen.
@en
Treatment of patients with rec ...... armacologically based regimen.
@nl
P2093
P2860
P1433
P1476
Treatment of patients with rec ...... armacologically based regimen.
@en
P2093
MacNeill K
Shulman LN
Sternberg DW
Thompson L
P2860
P304
P356
10.1002/(SICI)1097-0142(20000501)88:9<2037::AID-CNCR8>3.0.CO;2-K
P407
P577
2000-05-01T00:00:00Z